Linike Medical Group (LNMG) Fair Value & Analysis
Healthcare · US · Market cap $3.3M
Linike Medical Group
LNMG · US
Fair value as of: Jun 26, 2026
From 15 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.0036 to $0.0049 (+36.9%) since Jun 25, 2026. Share price −69.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0047 – $0.0368 · fair‑value band $0.0049 – $0.0050 · the $0.0050 price screens above the $0.0049 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Linike Medical Group (LNMG) currently trades at $0.0050, while our model-based Fair Value estimate is $0.0049 — implying the stock looks roughly 1.4% overvalued today. We read business quality at 43/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Net debt stands at $16.9M. Fundamentals as of Jun 26, 2026
About the company
Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.
Revenue & earnings trend
FY2012 – FY2025 · reported fiscal years
Linike Medical Group reported revenue of $10.7M in FY2025 versus $69.3K in FY2012, a compound +47.3%/yr. Reported net income was $3.1M in FY2025.
Is LNMG fairly valued? → Check now
Similar stocks
6 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABTT34 | R$37.76 | R$6.34 | -83% |
| Stryker Corporation S1YK34 | R$77.83 | R$8.47 | -89% |
| Medtronic plc MDT | $79.27 | $73.33 | -7% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EW | $87.45 | $41.02 | -53% |
| Siemens Healthineers AG SHL | €34.92 | €24.16 | -31% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Linike Medical Group (LNMG) undervalued?
What is the fair value of LNMG?
What is the quality score of LNMG?
What is the net profit margin of LNMG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.